Novel Mutation (Gly212Val) in the PS2 Gene Associated with Early-Onset Familial Alzheimer’s Disease

Juan Marín(Instituto Murciano de Investigación Biosanitaria), Fuensanta Noguera-Perea(Instituto Murciano de Investigación Biosanitaria), Estrella Gómez‐Tortosa(Hospital Universitario Fundación Jiménez Díaz), David López-Motos, Martirio Antequera-Torres(Instituto Murciano de Investigación Biosanitaria), B. Martínez(Instituto Murciano de Investigación Biosanitaria), Salvadora Manzanares(Instituto Murciano de Investigación Biosanitaria), L. Vivancos(Instituto Murciano de Investigación Biosanitaria), Agustina Legaz-García(Instituto Murciano de Investigación Biosanitaria), Alberto Rábano-Gutiérrez del Arroyo(Instituto de Salud Carlos III), Carmen Antúnez-Almagro(Instituto Murciano de Investigación Biosanitaria)
Journal of Alzheimer s Disease
June 22, 2016
Cited by 4

Abstract

Mutations in the presenilin 2 gene (PS2) are an extremely rare cause of early-onset autosomal dominant Alzheimer's disease (AD), accounting for only 5% of these families. These cases represent a particular model of AD, and the scarcity of reports on their clinical phenotypes makes them of great interest. We report a family with early-onset autosomal dominant AD in four members, where the two living siblings were found to carry the novel PS2 mutation Gly212Val (exon 7, transmembrane domain IV) with highly predicted pathogenicity. Age at onset ranged from 60 to 65 years and three of the cases died between ages 74 and 76 years. Clinical phenotype was quite homogeneous among affected members of the family, and overall features, including cognitive decline, tau/p-tau and amyloid-β cerebrospinal fluid markers, neuroimaging, and neuropathology were consistent with typical AD. Lewy bodies were present but restricted to the amygdala.


Related Papers

No related papers found

Powered by citation graph analysis